Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Piga

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
Minerva Medica|January 1, 1988
[Adrenal metastasis: clinical and pathological aspects]C Belleggia, A Piga, U Torresi, et al.
Acta Haematologica|January 1, 1980
Correlation between transfusion requirement, blood volume and haemoglobin level in homozygous beta-thalassaemiaV Gabutti, A Piga, P Fortina, et al.
AJR. American Journal of Roentgenology|November 1, 1994
MR imaging of hepatic masses: diagnostic significance of wedge-shaped areas of increased signal intensity surrounding the lesionA Giovagnoni, F Terilli, P Ercolani, et al.
Hematology (Amsterdam, Netherlands)|September 29, 2005
Combined use of oral chelators and desferrioxamine in thalassemiaA Piga, S Roggero, F Marletto, et al.
Annals of the New York Academy of Sciences|July 21, 1998
A multi-center safety trial of the oral iron chelator deferiproneA Cohen, R Galanello, A Piga, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 1, 1995
Continuing medical education through the videotex system in ItalyA Piga, F Graziano, R Bascioni, et al.
Current Therapeutic Research, Clinical and Experimental|July 1, 1976
Clinical therapeutic assessment of tobramycin (Nebramycin factor 6)B M Limson, E F Hipolito, S A Piga, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Effect of oral iron chelator L1 on iron absorption in manB Dresow, R Fischer, P Nielsen, et al.
Minerva Medica|September 8, 1980
[The use of betamethasone in polychemotherapy of lymphoproliferative diseases]R Cellerino, A Ambrosetti, D Tummarello, et al.
Cancer Treatment Reports|July 1, 1984
Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's diseaseA Piga, A Ambrosetti, G Todeschini, et al.
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Minerva Medica|January 1, 1988
[Adrenal metastasis: clinical and pathological aspects]C Belleggia, A Piga, U Torresi, et al.
Acta Haematologica|January 1, 1980
Correlation between transfusion requirement, blood volume and haemoglobin level in homozygous beta-thalassaemiaV Gabutti, A Piga, P Fortina, et al.
AJR. American Journal of Roentgenology|November 1, 1994
MR imaging of hepatic masses: diagnostic significance of wedge-shaped areas of increased signal intensity surrounding the lesionA Giovagnoni, F Terilli, P Ercolani, et al.
Hematology (Amsterdam, Netherlands)|September 29, 2005
Combined use of oral chelators and desferrioxamine in thalassemiaA Piga, S Roggero, F Marletto, et al.
Annals of the New York Academy of Sciences|July 21, 1998
A multi-center safety trial of the oral iron chelator deferiproneA Cohen, R Galanello, A Piga, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 1, 1995
Continuing medical education through the videotex system in ItalyA Piga, F Graziano, R Bascioni, et al.
Current Therapeutic Research, Clinical and Experimental|July 1, 1976
Clinical therapeutic assessment of tobramycin (Nebramycin factor 6)B M Limson, E F Hipolito, S A Piga, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Effect of oral iron chelator L1 on iron absorption in manB Dresow, R Fischer, P Nielsen, et al.
Minerva Medica|September 8, 1980
[The use of betamethasone in polychemotherapy of lymphoproliferative diseases]R Cellerino, A Ambrosetti, D Tummarello, et al.
Cancer Treatment Reports|July 1, 1984
Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's diseaseA Piga, A Ambrosetti, G Todeschini, et al.
Pageof 13